Pharmaceutical preparations for the treatment of Gram-positive bacterial infection, including, but not limited to, Staphylococcus aureus infection; pharmaceutical preparations for the treatment of drug-resistant strains of bacteria, including antibiotic-resistance bacterial infection; and pharmaceutical preparations for the treatment of infections related to Gram-positive bacteria and drug-resistant strains of bacteria, including, but not limited to, Staphylococcus aureus blood stream infections, Staphylococcus aureus bacteremia and endocarditis, including, but not limited to, right-sided infective endocarditis, including right-sided infective endocarditis caused by methicillin-susceptible and methicillin-resistant isolates

'antibiot':34 'antibiotic-resist':33 'aureus':18,65,70 'bacteremia':71 'bacteri':10,36 'bacteria':31,51,58 'blood':66 'caus':90 'drug':27,54 'drug-resist':26,53 'endocard':73,83,89 'gram':8,49 'gram-posit':7,48 'includ':12,32,59,74,84 'infect':11,19,37,45,68,82,88 'isol':99 'limit':15,62,77 'methicillin':93,97 'methicillin-resist':96 'methicillin-suscept':92 'pharmaceut':1,20,39 'posit':9,50 'prepar':2,21,40 'relat':46 'resist':28,35,55,98 'right':80,86 'right-sid':79,85 'side':81,87 'staphylococcus':17,64,69 'strain':29,56 'stream':67 'suscept':94 'treatment':5,24,43

LYSRUPTO

Owners

Goods & Services